Zupeng Luo

Nanning, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

MRPL44 regulates lipid metabolism in metabolic dysfunction-associated steatotic liver disease through BNIP3-mediated mitophagy.

MRPL44 regulates lipid metabolism in metabolic dysfunction-associated steatotic liver disease through BNIP3-mediated mitophagy.

Journal: Frontiers in nutrition
Published: July 09, 2025

Linarin alleviates high-fat diet-induced hepatic steatosis by inhibiting PDE4D and activating the cAMP/PKA/CREB pathway.

Linarin alleviates high-fat diet-induced hepatic steatosis by inhibiting PDE4D and activating the cAMP/PKA/CREB pathway.

Journal: Free radical biology & medicine
Published: May 17, 2025

Dual-omics analysis of transcriptome and translatome unveils lycopene-induced triglyceride accumulation mechanisms in muscle cells.

Dual-omics analysis of transcriptome and translatome unveils lycopene-induced triglyceride accumulation mechanisms in muscle cells.

Journal: Biochemical and biophysical research communications
Published: January 23, 2025

Comparative analysis of translatomics and transcriptomics in the longissimus dorsi muscle of Luchuan and Duroc pigs.

Comparative analysis of translatomics and transcriptomics in the longissimus dorsi muscle of Luchuan and Duroc pigs.

Journal: PloS one
Published: October 09, 2024

Liver knockout of MCU leads to greater dysregulation of lipid metabolism in MAFLD.

Liver knockout of MCU leads to greater dysregulation of lipid metabolism in MAFLD.

Journal: Scientific reports
Published: May 16, 2024

Corrigendum to "Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/ SLC7A11 pathway" [Redox Biol. 68 (2023) 102963].

Corrigendum to "Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/ SLC7A11 pathway" [Redox Biol. 68 (2023) 102963].

Journal: Redox biology
Published: December 02, 2023

Nardosinone relieves metabolic-associated fatty liver disease and promotes energy metabolism through targeting CYP2D6.

Nardosinone relieves metabolic-associated fatty liver disease and promotes energy metabolism through targeting CYP2D6.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 20, 2023

Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway.

Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway.

Journal: Redox biology
Published: September 18, 2023

BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism.

BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism.

Journal: eLife
Published: September 15, 2023

The Roles of Natural Alkaloids and Polyphenols in Lipid Metabolism: Therapeutic Implications and Potential Targets in Metabolic Diseases.

The Roles of Natural Alkaloids and Polyphenols in Lipid Metabolism: Therapeutic Implications and Potential Targets in Metabolic Diseases.

Journal: Current medicinal chemistry
Published: June 12, 2022

Genome-Wide Analysis of Long Non-coding RNAs Involved in Nodule Senescence in Medicago truncatula.

Genome-Wide Analysis of Long Non-coding RNAs Involved in Nodule Senescence in Medicago truncatula.

Journal: Frontiers in plant science
Published: April 11, 2022

Ruthenium 360 and mitoxantrone inhibit mitochondrial calcium uniporter channel to prevent liver steatosis induced by high-fat diet.

Ruthenium 360 and mitoxantrone inhibit mitochondrial calcium uniporter channel to prevent liver steatosis induced by high-fat diet.

Journal: British journal of pharmacology
Published: September 21, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026